Cancer Research Institute of Jiangsu Province, Nanjing, China.
J Hum Genet. 2010 Feb;55(2):97-102. doi: 10.1038/jhg.2009.129. Epub 2009 Dec 11.
To investigate the relationship among alcohol dehydrogenase-2 (ADH2) and aldehyde dehydrogenase-2 (ALDH2) genetic polymorphisms, alcohol consumption and the susceptibility to esophageal cancer in a Chinese population, we conducted a case-control study with 221 cases and 191 population-based controls in the Taixing city of Jiangsu Province of China. ADH2 and ALDH2 genotypes were examined using PCR and denaturing high-performance liquid chromatography. Alcohol drinkers with the ALDH2 A allele showed a significantly increased risk of esophageal cancer compared with drinkers with the ALDH2 G/G genotype (odds ratio (OR)=3.08, 95% confidence interval (CI): 1.65-5.78) or nondrinkers with any genotype (OR=3.05, 95% CI: 1.49-6.25). Drinkers with the ALDH2 A allele and a cumulative amount of alcohol consumption > or =2.5 (kg * years) were at a significantly higher risk of developing esophageal cancer (OR=11.93, 95% CI: 3.17-44.90) compared with individuals with ALDH2 G/G genotypes and a cumulative amount of alcohol consumption <2.5 (kg * years). A dose-dependent positive result was found between cumulative amount of alcohol consumption and risk of esophageal cancer in individuals carrying the ALDH2 A allele (P=0.023) and the homozygous ALDH2 G allele (P=0.047). Compared with individuals carrying both ALDH2 G/G and ADH2 A/A alleles and with a cumulative amount of alcohol consumption <2.5 (kg * years), drinkers carrying both ALDH2 A and ADH2 G alleles and with a cumulative amount of alcohol consumption > or =2.5 (kg * years) showed a significantly elevated risk of esophageal cancer (OR=53.15, 95% CI: 4.24-666.84). This result suggests that to help lower their risk for esophageal cancer, persons carrying the ALDH2 A allele should be encouraged to reduce their consumption of alcoholic beverages.
为了研究在中国人群中,酒精脱氢酶 2(ADH2)和醛脱氢酶 2(ALDH2)基因多态性、饮酒与食管癌易感性之间的关系,我们在中国江苏省泰兴市进行了一项病例对照研究,共纳入 221 例病例和 191 名基于人群的对照。使用 PCR 和变性高效液相色谱法检测 ADH2 和 ALDH2 基因型。与 ALDH2 G/G 基因型的饮酒者(比值比(OR)=3.08,95%置信区间(CI):1.65-5.78)或任何基因型的非饮酒者(OR=3.05,95%CI:1.49-6.25)相比,携带 ALDH2 A 等位基因的饮酒者患食管癌的风险显著增加。与 ALDH2 G/G 基因型且累积饮酒量<2.5(kg年)的个体相比,携带 ALDH2 A 等位基因且累积饮酒量≥2.5(kg年)的饮酒者患食管癌的风险显著更高(OR=11.93,95%CI:3.17-44.90)。在携带 ALDH2 A 等位基因的个体中,发现饮酒量与食管癌风险之间存在剂量依赖性正相关(P=0.023),在携带 ALDH2 G 纯合等位基因的个体中也存在这种相关性(P=0.047)。与同时携带 ALDH2 G/G 和 ADH2 A/A 等位基因且累积饮酒量<2.5(kg年)的个体相比,同时携带 ALDH2 A 和 ADH2 G 等位基因且累积饮酒量≥2.5(kg年)的饮酒者患食管癌的风险显著升高(OR=53.15,95%CI:4.24-666.84)。这些结果提示,携带 ALDH2 A 等位基因的个体应减少饮酒量,以降低患食管癌的风险。